Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ORMPORMP
28 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ORAMED PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 24,282 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $82,558 as of 2026-Q1.

Current Value

$82,558

Current Shares

24,282

Total Value Change

+$22,558

Total Shares Change

+7,325

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
24,282
0.0%
$82,5580.0%$3.38
0
2025-Q4
Unchanged
24,282
0.0%
$69,2030.0%$2.62
0
2025-Q3
Unchanged
24,282
0.0%
$64,1040.0%$2.52
0
2025-Q2
Decreased
24,282
-4.6%
$54,6340.0%$2.00
0
2025-Q1
Unchanged
25,455
0.0%
$54,4730.0%$2.06
0
2024-Q4
Unchanged
25,455
0.0%
$61,6010.0%$2.17
0
2024-Q3
Unchanged
25,455
0.0%
$62,1100.0%$2.31
0
2024-Q2
Unchanged
25,455
0.0%
$65,4190.0%$2.40
0
2024-Q1
Unchanged
25,455
0.0%
$74,3280.0%$2.72
0
2023-Q4
Increased
25,455
+21.7%
$58,8010.0%$2.15
17
2023-Q3
Unchanged
20,909
0.0%
$54,5720.0%$2.43
0
2023-Q2
Increased
20,909
+15.3%
$74,8540.0%$3.33
17
2023-Q1
Unchanged
18,130
0.0%
$39,5230.0%$2.01
0
2022-Q4
Unchanged
18,130
0.0%
$218,0000.0%$11.21
0
2022-Q3
Unchanged
18,130
0.0%
$117,0000.0%$6.05
0
2022-Q2
Decreased
18,130
-94.3%
$83,0000.0%$4.20
0
2022-Q1
Increased
321,159
+30.9%
$2.8M0.0%$8.41
33
2021-Q4
Decreased
245,345
-0.7%
$3.5M0.0%$12.79
0
2021-Q3
Increased
246,971
+13.4%
$5.4M0.0%$20.83
31
2021-Q2
Increased
217,708
+1183.9%
$2.9M0.0%$12.47
42
2021-Q1
Unchanged
16,957
0.0%
$172,0000.0%$9.43
0
2020-Q4
Unchanged
16,957
0.0%
$71,0000.0%$4.07
0
2020-Q3
Unchanged
16,957
0.0%
$44,0000.0%$2.41
0
2020-Q2
Unchanged
16,957
0.0%
$59,0000.0%$3.25
0
2020-Q1
Unchanged
16,957
0.0%
$51,0000.0%$2.78
0
2019-Q4
Unchanged
16,957
0.0%
$87,0000.0%$4.62
0
2019-Q3
Unchanged
16,957
0.0%
$54,0000.0%$2.89
0
2019-Q2
New
16,957
-
$60,0000.0%$3.35
32

Other major holders of ORMP: Invesco Ltd., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MERCER GLOBAL ADVISORS INC /ADV

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used